S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20

Balchem Stock Forecast, Price & News

-4.28 (-2.52%)
(As of 11/26/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
67,431 shs
Average Volume
112,072 shs
Market Capitalization
$5.35 billion
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive BCPC News and Ratings via Email

Sign-up to receive the latest news and ratings for Balchem and its competitors with MarketBeat's FREE daily newsletter.

Balchem logo

About Balchem

Balchem Corp. provides marketing of specialty performance ingredients and products. It operates through the following segments: Human Nutrition and Health, Animal Nutrition and Health, Specialty Products and Industrial Products. The Human Nutrition and Health segment supplies ingredients in the food and beverage industry, providing customized solutions in powder, solid and liquid flavor delivery systems, spray dried emulsified powder systems, and cereal systems. The Animal Nutrition and Health segment comprises nutritional products derived from microencapsulation and chelation technologies in addition to basic choline chloride. The Specialty Products segment offers Ethylene oxide for the health care industry. The Industrial Products segment refers to certain derivatives of choline chloride which manufactured and sold into industrial applications as a component for hydraulic fracturing of shale natural gas wells. The company was founded in January 1967 and is headquartered in New Hampton, NY.


Balchem (NASDAQ:BCPC) Hits New 52-Week High at $167.98
November 18, 2021 |  americanbankingnews.com
Balchem (NASDAQ:BCPC) Hits New 1-Year High at $165.61
November 12, 2021 |  americanbankingnews.com
Balchem (NASDAQ:BCPC) Reaches New 52-Week High at $157.24
November 3, 2021 |  americanbankingnews.com
See More Headlines

Industry, Sector and Symbol

Chemicals & allied products
Specialty Chemicals
Current Symbol
Year Founded

Sales & Book Value

Annual Sales
$703.64 million
Cash Flow
$4.79 per share
Book Value
$27.46 per share


Net Income
$84.62 million
Pretax Margin




Free Float
Market Cap
$5.35 billion

Company Calendar

Last Earnings
Fiscal Year End
Next Earnings (Estimated)

Social Links


Overall MarketRank

1.99 out of 5 stars

Basic Materials Sector

130th out of 223 stocks

Chemicals & Allied Products Industry

15th out of 20 stocks

Analyst Opinion: 1.3Community Rank: 4.5Dividend Strength: 2.5Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -

Balchem (NASDAQ:BCPC) Frequently Asked Questions

Is Balchem a buy right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Balchem in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" Balchem stock.
View analyst ratings for Balchem
or view top-rated stocks.

How has Balchem's stock been impacted by Coronavirus (COVID-19)?

Balchem's stock was trading at $89.29 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, BCPC stock has increased by 85.1% and is now trading at $165.28.
View which stocks have been most impacted by COVID-19

When is Balchem's next earnings date?

Balchem is scheduled to release its next quarterly earnings announcement on Friday, February 18th 2022.
View our earnings forecast for Balchem

How were Balchem's earnings last quarter?

Balchem Co. (NASDAQ:BCPC) issued its earnings results on Thursday, October, 28th. The basic materials company reported $0.92 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $0.90 by $0.02. The basic materials company earned $197.87 million during the quarter, compared to the consensus estimate of $204.80 million. Balchem had a net margin of 12.17% and a trailing twelve-month return on equity of 13.46%. During the same period last year, the company posted $0.83 EPS.
View Balchem's earnings history

How often does Balchem pay dividends? What is the dividend yield for Balchem?

Balchem announced an annual dividend on Thursday, December 17th. Stockholders of record on Monday, December 28th will be given a dividend of $0.58 per share on Friday, January 22nd. This represents a dividend yield of 0.5%. The ex-dividend date of this dividend is Thursday, December 24th. This is a boost from Balchem's previous annual dividend of $0.26.
View Balchem's dividend history

Is Balchem a good dividend stock?

Balchem pays an annual dividend of $0.58 per share and currently has a dividend yield of 0.34%. Balchem has been increasing its dividend for 10 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of Balchem is 20.21%. This payout ratio is at a healthy, sustainable level, below 75%.
View Balchem's dividend history.

What price target have analysts set for BCPC?

2 brokerages have issued twelve-month target prices for Balchem's stock. Their forecasts range from $145.00 to $160.00. On average, they anticipate Balchem's stock price to reach $152.50 in the next year. This suggests that the stock has a possible downside of 7.7%.
View analysts' price targets for Balchem
or view top-rated stocks among Wall Street analysts.

Who are Balchem's key executives?

Balchem's management team includes the following people:
  • Theodore L. Harris, Chairman, President & Chief Executive Officer
  • Martin Bengtsson, Chief Financial Officer & Treasurer
  • Jeff McCartney, Senior Director-Information Technology
  • Michael Sestrick, Chief Technology Officer
  • James Hyde, SVP & General Manager-Human Health & Nutrition

What is Dino A. Rossi's approval rating as Balchem's CEO?

15 employees have rated Balchem CEO Dino A. Rossi on Glassdoor.com. Dino A. Rossi has an approval rating of 85% among Balchem's employees.

What other stocks do shareholders of Balchem own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Balchem investors own include Ecolab (ECL), CVS Health (CVS), AbbVie (ABBV), Johnson & Johnson (JNJ), Lowe's Companies (LOW), Altria Group (MO), NVIDIA (NVDA), AT&T (T), Analog Devices (ADI) and Bristol-Myers Squibb (BMY).

What is Balchem's stock symbol?

Balchem trades on the NASDAQ under the ticker symbol "BCPC."

Who are Balchem's major shareholders?

Balchem's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (14.67%), Wasatch Advisors Inc. (5.65%), Conestoga Capital Advisors LLC (3.08%), Geneva Capital Management LLC (2.06%), Schroder Investment Management Group (1.80%) and Geode Capital Management LLC (1.72%). Company insiders that own Balchem stock include Scott C Mason and William A Backus.
View institutional ownership trends for Balchem

Which major investors are selling Balchem stock?

BCPC stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Schroder Investment Management Group, New York State Common Retirement Fund, Macquarie Group Ltd., Morgan Stanley, Eaton Vance Management, Assenagon Asset Management S.A., and Segall Bryant & Hamill LLC.
View insider buying and selling activity for Balchem
or view top insider-selling stocks.

Which major investors are buying Balchem stock?

BCPC stock was purchased by a variety of institutional investors in the last quarter, including Wasatch Advisors Inc., Allianz Asset Management GmbH, Nordea Investment Management AB, Conestoga Capital Advisors LLC, BNP Paribas Arbitrage SA, Goldman Sachs Group Inc., Invesco Ltd., and Skandinaviska Enskilda Banken AB publ .
View insider buying and selling activity for Balchem
or or view top insider-buying stocks.

How do I buy shares of Balchem?

Shares of BCPC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Balchem's stock price today?

One share of BCPC stock can currently be purchased for approximately $165.28.

How much money does Balchem make?

Balchem has a market capitalization of $5.35 billion and generates $703.64 million in revenue each year. The basic materials company earns $84.62 million in net income (profit) each year or $2.87 on an earnings per share basis.

How many employees does Balchem have?

Balchem employs 1,342 workers across the globe.

When was Balchem founded?

Balchem was founded in 1967.

What is Balchem's official website?

The official website for Balchem is www.balchem.com.

Where are Balchem's headquarters?

Balchem is headquartered at 52 Sunrise Park Road, NEW HAMPTON NY, 10958.

How can I contact Balchem?

Balchem's mailing address is 52 Sunrise Park Road, NEW HAMPTON NY, 10958. The basic materials company can be reached via phone at (845) 326-5600, via email at [email protected], or via fax at 845-326-5717.

This page was last updated on 11/27/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.